Our Leadership

The board of directors of PhRMA includes senior leaders representing the world’s top developers of new treatments and cures who are committed to improving health care through innovation and research. The senior executive team at PhRMA works closely with the board of directors to advance policies that ensure continued investment in biopharmaceutical innovation.

Leadership

Board of Directors

Photograph of Peter Anastasiou, Executive Vice President and Head of North America, Lundbeck

Peter Anastasiou

Executive Vice President and Head of North America
Lundbeck

-

Read More
Photograph of Jean-Michel Boers, President of Boehringer Ingelheim Pharmaceuticals, Inc.

Jean-Michel Boers

U.S. Country Managing Director, President and CEO
Boehringer Ingelheim Pharmaceuticals, Inc.

-

read more
A photograph of Alexander Hardy, Chief Executive Officer of Genentech

Alexander Hardy

Chief Executive Officer
Genentech

-

read more
A picture of Ken Keller

Ken Keller

President and Chief Executive Officer
Daiichi Sankyo, Inc.

-

Read More
Picture of Kabir K. Nath

Kabir K. Nath

President & CEO
Otsuka North America Pharmaceutical Business

-

Read More

Senior Executives

Stephen J. Ubl

President and Chief Executive Officer

-

Read More

Richard Moscicki, M.D.

Chief Medical Officer and Executive Vice President of Science and Regulatory Advocacy

-

Read More

Paul Aines

Chief Financial Officer and Executive Vice President of Administration

-

Read More

Lori M. Reilly, Esq.

Chief Operating Officer 

-

read more

James C. Stansel

Executive Vice President and General Counsel

-

Read More
Jennifer Bryant

Jennifer Bryant

Executive Vice President of Policy and Research

-

read more